Cormorant Asset Management’s Prime Medicine PRME Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-734,350	Closed	-$9.03M	–	70
2023 Q1	$9.03M	Hold	734,350	–	–	0.59%	41
2022 Q4	$13.6M	Buy	+734,350	New	+$13.6M	0.91%	33